Both in Biotechnology
Invivyd vs Protalix BioTherapeutics
Over the past year IVVD returned −60.7% and PLX returned +13.8%; their daily moves had a correlation of 0.19.
IVVD −60.7% PLX +13.8%Growth of $1, one year, split-adjusted
| Metric | IVVD | PLX |
|---|---|---|
| Price | $0.6334 | $2.72 |
| Market cap | $186.7M | $219.2M |
| Today | +8.93% | +4.21% |
| 1 month | −21.4% | −0.4% |
| 6 months | −56.6% | +34.7% |
| Year to date | −74.4% | +51.1% |
| 1 year | −60.7% | +13.8% |
| Revenue growth (YoY) | +21.2% | +27.1% |
| Gross margin | 91.1% | 61.0% |
| Net margin | −310.8% | 19.0% |
| P/E (TTM) | — | 11.6× |
| Price / sales | 3.2× | 2.7× |
| Net cash | $160.1M | $40.7M |
| Dividend yield | — | — |
| Volatility (60d) | 107.6% | 45.3% |
| Short % of float | 15.5% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).